۱ | Refractory and Recurrent Idiopathic Granulomatous Mastitis Treatment: Adaptive, Randomized Clinical Trial | Shojaeian F., Haghighat S., Abbasvandi F., (...), Nafissi N., Najafi S. | Journal of the American College of Surgeons | 2024-6-1 |
۲ | Efficacy and safety of diphereline 11.25 mg, microrelin 11.25 mg, and microrelin 3.75 mg in premenopausal patients with breast cancer: a non-inferiority randomized clinical trial | Najafi, S., Ansari, M., Omidi, Z., (...), Najafi, N., Haghighat, | BMC Cancer, | 2023-12-1 |
۳ | Idiopathic Granulomatous Mastitis: An institutional Experience from a Referral Center | Sari, F., Raei, N., Najafi, S., (...), Moghadam, S., Olfatbakhsh, A. | Archives of Breast Cance | 2022-7-1 |
۴ | Evaluation of PIK3CA Gene Mutations in Breast Cancer Patients Treated by Trastuzumab | Nazeri, E., Parniani, M., Olfatbakhsh, A., (...), Halvaei, S., Esmaeili, R. | Archives of Breast Cancer | 2023-8-1 |
۵ | Evaluation of PIK3CA Gene Mutations in Breast Cancer Patients Treated by Trastuzumab | Nazeri, E., Parniani, M., Olfatbakhsh, A., (...), Halvaei, S., Esmaeili, R. | Archives of Breast Cancer, | 2023-8-1 |
۶ | Newly Developed Targeted Therapies Against the Androgen Receptor in Triple-Negative Breast Cancer: A Review | Choupani, E., Gomari, M.M., Zanganeh, S., (...), Saraygord-Afshari, N., Hosseini, A. | Pharmacological Reviews, | 2023-3-1 |
۷ | Non-thermal CO2 Laser Therapy (NTCLT): A Novel Photobiomodulative Approach for Immediate Pain Relief of Patchy Oral Mucositis Due to Chemotherapy of Solid Tumors | Zand, N., Najafi, S., Fateh, M., (...), Mahdavi, H., Shirkavand, A. | Journal of Lasers in Medical Sciences, | 2023 |
۸ | Comparing efficacy and safety of P013, a proposed pertuzumab biosimilar, with the reference product in HER2-positive breast cancer patients: a randomized, phase III, equivalency clinical trial | Allahyari, A., Ehsanpour, A., Ansarinejad, N., (...), Kafi, H., Najafi, S. | BMC Cancer | 2022-12-1 |
۹ | Correction: Comparing efficacy and safety of P013, a proposed pertuzumab biosimilar, with the reference product in HER2-positive breast cancer patients: a randomized, phase III, equivalency clinical trial (BMC Cancer, (2022), 22, 1, (960), 10.1186/s12885- | Allahyari, A., Ehsanpour, A., Najafi, B., (...), Kaf, H., Najaf, S. | BMC Cancer, | 2022-12-1 |
۱۰ | Preferences of Patients With HR+ & HER2- Breast Cancer Regarding Hormonal and Targeted Therapies in the First Line of Their Metastatic Stage: A Discrete Choice Experiment | Nazari, A., Lopez-Valcarcel, B.G., Najafi, S. | Value in Health Regional Issues | 2021-9-1 |
۱۱ | Effects of synbiotic supplementation on serum adiponectin and inflammation status of overweight and obese breast cancer survivors: a randomized, triple-blind, placebo-controlled trial | Raji Lahiji, M., Zarrati, M., Najafi, S., (...), Raji Lahiji, M., Shidfar, F. | Supportive Care in Cancer, | 2021-7-1 |
۱۲ | The effect of synbiotic on glycemic profile and sex hormones in overweight and obese breast cancer survivors following a weight-loss diet: A randomized, triple-blind, controlled trial | Raji Lahiji, M., Najafi, S., Janani, L., (...), Razmpoosh, E., Zarrati, M. | Clinical Nutrition | 2021-2-1 |
۱۳ | Comparing the efficacy and side-effects of PDLASTA® (Pegfilgrastim) with PDGRASTIM® (Filgrastim) in breast cancer patients: a non-inferiority randomized clinical trial | Najafi, S., Ansari, M., Kaveh, V., Haghighat, S. | BMC Cancer | 2021-12-1 |
۱۴ | Lithium and preventing chemotherapy-induced peripheral neuropathy in breast cancer patients: a placebo-controlled randomized clinical trial | Najafi, S., Heidarali, Z., Rajabi, M., (...), Salehi, M., Haghighat, S. | Trials | 2021-12-1 |
۱۵ | Efficacy and Safety of Proposed Bevacizumab Biosimilar BE1040V in Patients With Metastatic Colorectal Cancer: A Phase III, Randomized, Double-blind, Noninferiority Clinical Trial | Rezvani, H., Mortazavizadeh, S.M., Allahyari, A., (...), Karbalaeian, M., Salari, S. | Clinical Therapeutics | 2020-5-1 |
۱۶ | Predicting the determinants of nutritional behaviors among high school female students: The application of extended theory of reasoned action | Baji, Z., Shakerinejad, Gh., Tehrani, M., Jarvandi, F., Najaf, S.H. | Journal of Education and Community Health, | 2020-3-1 |
۱۷ | The impact of hormone receptor status on survival and recurrence of HER2-positive breast cancers in standard adjuvant setting: A retrospective study in Tehran, Iran | Najafi, S., Sadeghi, M., Shajari, M.R., Abasvandi, F., Mohebi, K. | Journal of the Pakistan Medical Association | 2020-1-1 |
۱۸ | The Effect of Dietary Intervention Along with Nutritional Education on Reducing the Gastrointestinal Side Effects Caused by Chemotherapy Among Women with Breast Cancer | Abdollahi, R., Najafi, S., Razmpoosh, E., (...), Cheshmazar, E., Zarrati, M. | Nutrition and Cancer, | 2019-8-18 |
۱۹ | Randomized Study of the Effect of Dietary Counseling During Adjuvant Chemotherapy on Chemotherapy Induced Nausea and Vomiting, and Quality of Life in Patients With Breast Cancer | Najafi, S., Haghighat, S., Raji Lahiji, M., (...), Asgari, M., Zarrati, M. | Nutrition and Cancer, | 2019-5-19 |
۲۰ | The incidence of deep vein thrombosis in breast cancer patients receiving outpatient cancer therapy in Iran | Sharif-Kashani, B., Motlagh, A.G., Mafi, A.R., (...), Taghizadeh, A., Najafi, S. | Tanaffos | 2019 |